BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

393 related articles for article (PubMed ID: 26848625)

  • 1. Long non-coding RNA FEZF1-AS1 facilitates cell proliferation and migration in colorectal carcinoma.
    Chen N; Guo D; Xu Q; Yang M; Wang D; Peng M; Ding Y; Wang S; Zhou J
    Oncotarget; 2016 Mar; 7(10):11271-83. PubMed ID: 26848625
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The lncRNA FEZF1-AS1 Promotes the Progression of Colorectal Cancer Through Regulating OTX1 and Targeting miR-30a-5p.
    Li J; Zhao LM; Zhang C; Li M; Gao B; Hu XH; Cao J; Wang GY
    Oncol Res; 2020 Feb; 28(1):51-63. PubMed ID: 31270006
    [TBL] [Abstract][Full Text] [Related]  

  • 3. lncRNA FEZF1-AS1 Is Associated With Prognosis in Lung Adenocarcinoma and Promotes Cell Proliferation, Migration, and Invasion.
    Liu Z; Zhao P; Han Y; Lu S
    Oncol Res; 2018 Dec; 27(1):39-45. PubMed ID: 29510777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long non-coding RNA TP73-AS1 sponges miR-194 to promote colorectal cancer cell proliferation, migration and invasion via up-regulating TGFα.
    Cai Y; Yan P; Zhang G; Yang W; Wang H; Cheng X
    Cancer Biomark; 2018; 23(1):145-156. PubMed ID: 30010111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LncRNA-FEZF1-AS1 Promotes Tumor Proliferation and Metastasis in Colorectal Cancer by Regulating PKM2 Signaling.
    Bian Z; Zhang J; Li M; Feng Y; Wang X; Zhang J; Yao S; Jin G; Du J; Han W; Yin Y; Huang S; Fei B; Zou J; Huang Z
    Clin Cancer Res; 2018 Oct; 24(19):4808-4819. PubMed ID: 29914894
    [No Abstract]   [Full Text] [Related]  

  • 6. Long non-coding RNA ZNFX1-AS1 promotes the tumor progression and metastasis of colorectal cancer by acting as a competing endogenous RNA of miR-144 to regulate EZH2 expression.
    Shi L; Hong X; Ba L; He X; Xiong Y; Ding Q; Yang S; Peng G
    Cell Death Dis; 2019 Feb; 10(3):150. PubMed ID: 30770796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Upregulated NNT-AS1, a long noncoding RNA, contributes to proliferation and migration of colorectal cancer cells in vitro and in vivo.
    Wang Q; Yang L; Hu X; Jiang Y; Hu Y; Liu Z; Liu J; Wen T; Ma Y; An G; Feng G
    Oncotarget; 2017 Jan; 8(2):3441-3453. PubMed ID: 27966450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long noncoding RNA FEZF1-AS1 indicates a poor prognosis of gastric cancer and promotes tumorigenesis via activation of Wnt signaling pathway.
    Wu X; Zhang P; Zhu H; Li S; Chen X; Shi L
    Biomed Pharmacother; 2017 Dec; 96():1103-1108. PubMed ID: 29239821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Role of lncRNA Fez family zinc finger protein 1 antisense RNA1 in hepatocellular carcinoma].
    Yao J; Wang XP; Zhang ZZ; Yang J; Yang Z; Qian HX
    Zhonghua Zhong Liu Za Zhi; 2019 Sep; 41(9):667-674. PubMed ID: 31550856
    [No Abstract]   [Full Text] [Related]  

  • 10. Oncogenic lncRNA ZNF561-AS1 is essential for colorectal cancer proliferation and survival through regulation of miR-26a-3p/miR-128-5p-SRSF6 axis.
    Si Z; Yu L; Jing H; Wu L; Wang X
    J Exp Clin Cancer Res; 2021 Feb; 40(1):78. PubMed ID: 33622363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long non-coding RNA FEZF1-AS1 promotes cell invasion and epithelial-mesenchymal transition through JAK2/STAT3 signaling pathway in human hepatocellular carcinoma.
    Wang YD; Sun XJ; Yin JJ; Yin M; Wang W; Nie ZQ; Xu J
    Biomed Pharmacother; 2018 Oct; 106():134-141. PubMed ID: 29957463
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long non-coding RNA AFAP1-AS1 facilitates tumor growth and promotes metastasis in colorectal cancer.
    Han X; Wang L; Ning Y; Li S; Wang Z
    Biol Res; 2016 Aug; 49(1):36. PubMed ID: 27578191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long non-coding RNA FOXP4-AS1 is an unfavourable prognostic factor and regulates proliferation and apoptosis in colorectal cancer.
    Li J; Lian Y; Yan C; Cai Z; Ding J; Ma Z; Peng P; Wang K
    Cell Prolif; 2017 Feb; 50(1):. PubMed ID: 27790757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long Noncoding RNA FEZF1-AS1 Promotes Proliferation and Inhibits Apoptosis in Ovarian Cancer by Activation of JAK-STAT3 Pathway.
    Zhao X; Cheng Z; Wang J
    Med Sci Monit; 2018 Nov; 24():8088-8095. PubMed ID: 30416194
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long noncoding RNA FEZF1-AS1 in human cancers.
    Zhou Y; Xu S; Xia H; Gao Z; Huang R; Tang E; Jiang X
    Clin Chim Acta; 2019 Oct; 497():20-26. PubMed ID: 31276636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LncRNA SATB2-AS1 inhibits tumor metastasis and affects the tumor immune cell microenvironment in colorectal cancer by regulating SATB2.
    Xu M; Xu X; Pan B; Chen X; Lin K; Zeng K; Liu X; Xu T; Sun L; Qin J; He B; Pan Y; Sun H; Wang S
    Mol Cancer; 2019 Sep; 18(1):135. PubMed ID: 31492160
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Silencing of lncRNA EZR-AS1 inhibits proliferation, invasion, and migration of colorectal cancer cells through blocking transforming growth factor β signaling.
    Liu Z; Wang N; Wang F; Zhang S; Ding J
    Biosci Rep; 2019 Nov; 39(11):. PubMed ID: 31693738
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LncRNA FEZF1-AS1 promotes colorectal cancer progression through regulating the miR-363-3p/PRRX1 pathway.
    Zhang T; Yu S; Zhao S
    Adv Clin Exp Med; 2021 Aug; 30(8):839-848. PubMed ID: 34286520
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long noncoding RNA TPT1-AS1 promotes the progression and metastasis of colorectal cancer by upregulating the TPT1-mediated FAK and JAK-STAT3 signalling pathways.
    Zhang L; Ye F; Zuo Z; Cao D; Peng Y; Li Z; Huang J; Duan L
    Aging (Albany NY); 2021 Jan; 13(3):3779-3797. PubMed ID: 33428595
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long non-coding RNA SOX21-AS1 sponges miR-145 to promote the tumorigenesis of colorectal cancer by targeting MYO6.
    Wei AW; Li LF
    Biomed Pharmacother; 2017 Dec; 96():953-959. PubMed ID: 29217166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.